United States · FDA National Drug Code directory
Survanta
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0074-1040_6ff1e6a7-1578-4e78-b34f-eb204b23554c
- Product NDC
- 0074-1040
- Form
- SUSPENSION
- Composition / generic term
- Beractant
- Labeler
- AbbVie Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 19910701
- Source listing expiry
- 20261231
Source-listed ingredients
- BERACTANT — 25 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-USE in 1 CARTON (0074-1040-04) / 4 mL in 1 VIAL, SINGLE-USE · 0074-1040-04
- 1 VIAL, SINGLE-USE in 1 CARTON (0074-1040-08) / 8 mL in 1 VIAL, SINGLE-USE · 0074-1040-08
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →